SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

NVCR

NovoCure Ltd.
NASDAQHealth Care

Latest close: 14.07 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,11912 flagged findings
Reported transactions (Form 4)80since Jun 5, 2024 · and 40 other holdings
Corporate events (8-K)30since Mar 6, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-04-30share offering or dilution eventrecentOpen filing ↗
    “…income (expenses), net. Financial income decreased by $ 9.4 million or 124% from $7.6 million in income for the three months ended…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,119)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 1, 268-K ↗Current report · Communication to the market
  • Sep 9, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 1, 268-K ↗Current report · Other events
  • Jul 23, 26Form 144 ↗Notice of proposed sale
  • Jul 23, 268-K ↗Current report · Results
  • Jul 23, 2610-Q ↗Quarterly report
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Jun 30, 268-K ↗Current report · Communication to the market
  • Jun 18, 268-K ↗Current report · Communication to the market
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Jun 5, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Jun 4, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 2 Form 4 filingsshow all 2hide

1,119 filings on record, the oldest from Oct 1, 15.

Listing the 25 most recent filings of the 1,119 on record.

8-Ks, explained

Stress1Structure19Governance38
  • Governance14 senior executive changes2022 – 2026show all 14hide
    • Sep 9, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jun 5, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Apr 24, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K/A 5.02 ↗
    • Apr 9, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Dec 1, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jun 6, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Dec 17, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K/A 5.02 ↗
    • Oct 30, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Sep 3, 24GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
    • Jun 10, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jan 4, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jun 8, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Mar 29, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jun 10, 22GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • May 26, 22StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Apr 13, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 7, 21StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 11, 21GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Feb 8, 21GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Nov 9, 20StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Nov 5, 20StructureSold unregistered shares+4 more in the same filing8-K 3.02 ↗
  • Aug 13, 20GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • Aug 6, 20StressA debt obligation was accelerated+1 more in the same filing8-K 2.04 ↗
  • Governance3 senior executive changes2020show all 3hide
    • Jun 12, 20GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 24, 20GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 6, 20GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗

The record reaches back to Dec 22, 15.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Jul 23, NICOLAS LEUPIN filed notice of intent to sell up to $609K. That is about 0.03% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 4, 26Sell$615KFrank X LeonardChief Executive Officer↗
  • Jun 2, 26Sell$46KAllyson J Ocean↗
  • Jun 2, 26Sell$46KJERYL L HILLEMAN↗
  • Jun 2, 26Sell$46KGABRIEL LEUNG↗
  • Jun 2, 26Sell$46KDavid Hung↗
  • Jun 2, 26Sell$46KW ANTHONY VERNON↗
  • Jun 2, 26Sell$46KTimothy J Scannell↗
  • Mar 5, 26Sell$596KMukund ParavasthuChief Operating Officer↗
  • Mar 4, 26Sell$85KUri WeinbergChf Medical and Innovation Ofr↗
  • Mar 4, 26Sell$75KFrank X LeonardChief Executive Officer↗
  • Mar 4, 26Sell$15KMichal Nath PuriChief Human Resources Officer↗
  • Mar 4, 26Sell$15KNicolas LeupinFormer Chief Medical Officer↗

There are 5 more transactions in this stretch.

Stock compensation, tax and giftsshow the 23 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 30, 26Compensation$3KAsaf Danziger↗
  • Jun 30, 26Compensation$21KFrank X LeonardChief Executive Officer↗
  • Jun 30, 26Compensation$14KArye Barak BenGeneral Counsel↗
  • Jun 30, 26Compensation$21KMichal Nath PuriChief Human Resources Officer↗
  • Jun 3, 26Compensationamount n/aAllyson J Ocean↗
  • Jun 3, 26Compensationamount n/aJERYL L HILLEMAN↗
  • Jun 3, 26Compensationamount n/aGABRIEL LEUNG↗
  • Jun 3, 26Compensationamount n/aDavid Hung↗
  • Jun 3, 26Compensationamount n/aW ANTHONY VERNON↗
  • Jun 3, 26Compensationamount n/aTimothy J Scannell↗
  • Jun 3, 26Compensationamount n/aMartin J. Madden↗
  • Apr 28, 26Compensation$245KW ANTHONY VERNON↗
  • Mar 4, 26Tax$235KAshley CordovaFormer Chief Executive Officer↗
  • Mar 3, 26Compensationamount n/aWILLIAM F DOYLEExecutive Chairman↗
  • Mar 3, 26Compensationamount n/aWILLIAM F DOYLEExecutive Chairman↗
  • Mar 3, 26Compensationamount n/aUri WeinbergChf Medical and Innovation Ofr↗
  • Mar 3, 26Compensationamount n/aFrank X LeonardChief Executive Officer↗
  • Mar 3, 26Compensationamount n/aArye Barak BenGeneral Counsel↗
  • Mar 3, 26Compensationamount n/aMichal Nath PuriChief Human Resources Officer↗
  • Mar 3, 26Compensationamount n/aMukund ParavasthuChief Operating Officer↗
  • Mar 3, 26Compensationamount n/aChristoph BrackmannChief Financial Officer↗
  • Mar 2, 26Tax$33KAshley CordovaFormer Chief Executive Officer↗
  • Mar 2, 26Tax$99KAshley CordovaFormer Chief Executive Officer↗

The full record holds 258 transactions and goes back to Jan 5, 23.

Its sector and its market

NovoCure Ltd. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From NovoCure Ltd., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow NovoCure Ltd. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,119 documents on file, from Oct 1, 2015 to Oct 1, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

NovoCure Ltd. (NVCR): stock price history, insider trades and SEC filings — HornScout